Ingelheim, Germany, January 16, 2025 - Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive...

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, announced top─line results from the phase III CONNEX...

In a finding with implications for one of the most promising cutting-edge medical treatments, researchers evaluated several measurement techniques...

ProMIS Neurosciences Inc., a clinical─stage biotechnology company focused on developing precision therapies for neurodegenerative diseases,...

GenSight Biologics, a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and...

Valneva reports positive data from its Phase 3 - VLA1553-321 study of the IXCHIQ vaccine.

Van Oord is making significant progress on the Constanța Beaches (phase III) project in Romania. The beach reinforcement works at […]

Thousands of Belize City residents will now have to access primary health care at little to no cost at a new facility opened under the National Health...

This year’s Prototype, a showcase of experimental opera and theater, was stylistically broad but the focus was on the human voice in all its...

The GSLV-F15 rocket with indigenous cryogenic stage will place NVS-02 satellite in a Geosynchronous Transfer Orbit.